Application of neuroimaging markers in the regulation of anxiety symptoms in remote attention bias correction therapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064187

Enrollment

Unknown

Registered

2022-09-29

Start date

2022-09-30

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety disorders

Interventions

Intervention group:Neutral attention task

control group:Negative attention task

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. GAD-7 score > 5 (above moderate anxiety); 2. Aged 18-55 years; 3. No psychotropic drugs were received during the study period; 4. Volunteer to participate in this study and sign the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Have a history of serious physical and neurological diseases; 2. There are obvious self injury or suicide concepts and behaviors; 3. Past or present schizophrenia, bipolar disorder, schizophrenic affective disorder, obsessive-compulsive disorder; 4. Dependence on alcohol and other psychoactive substances; 5. There is generalized developmental disorder.

Design outcomes

Primary

Measure	Time frame
Structured clinical interview for DSM-IV axis I disorders-Patient edition;Hamilton Depression Scale;Hamilton Anxiety Scale;Patient Health Questionnaire-9;Health Questionnaire-15;Generalized Anxiety Disorder;Clinical Global Impression;	—

Countries

China

Contacts

Public ContactHongru Zhu

West China Hospital, Sichuan University

zhuhongru@outlook.com+86 18980682131

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026